From FY2026, focused restructuring, renewed R&D focus, and efficiency and digital initiatives will deliver near-term cost savings to enhance our path to profitability, including an expected minimum ...

Through years of participation in the CIIE, German pharmaceutical company Boehringer Ingelheim has evolved from an exhibitor ...

Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...

Palatin (($PTN)) has held its Q1 earnings call. Read on for the main highlights of the call. Palatin’s recent earnings call painted a largely ...

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

Mikael Dolsten, the longtime Pfizer executive who led the companys research and development operations, has withdrawn his ...

Ulcerative colitis is a chronic, immune-mediated disorder of the colon, which is characterised by a relapsing–remitting course. Owing to the growing understanding of the immunopathogenesis of this ...

Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing ...

(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's ...

UCSF researchers are studying whether large language models, a type of artificial intelligence (AI), can analyze the clinical notes of multiple physicians and other care providers to improve the ...

The decision to pause dapiglutide will help Zealand focus investment into assets that have “the greatest potential for ...